申请人:The Du Pont Merck Pharmaceutical Company
公开号:US05376666A1
公开(公告)日:1994-12-27
Novel heterocycle substituted azocycloalkane benzylimidazoles of Formula (I), which are useful as angiotensin-II antagonists, are disclosed: ##STR1##
新型杂环取代的偶氮环戊基咪唑啉化合物,可用作抗高血压药物,其化学式如下:##STR1##